Literature DB >> 15860963

Hypertensive heart disease.

L Michael Prisant1.   

Abstract

Hypertensive heart disease encompasses anatomical changes and altered physiology of heart muscle, coronary arteries, and great vessels. Left ventricular hypertrophy is not only a target organ response to increased afterload, but is also the most potent cardiovascular risk factor. Regression of hypertrophy reduces morbidity and mortality. Heart failure may be present in the absence of a reduction of myocardial contractility. Ischemic heart disease occurs in the absence of epicardial coronary disease. Left atrial size and atrial fibrillation are associated. Potentially lethal ventricular arrhythmias and sudden cardiac death are more common in hypertensive patients. The relationship of aortic root size to blood pressure is weaker than expected; however, the relationship to aortic dissection is stronger. Careful attention and treatment of left ventricular hypertrophy, heart failure, ischemic heart disease, and atrial fibrillation will improve survival.

Entities:  

Mesh:

Year:  2005        PMID: 15860963      PMCID: PMC8109725     

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  10 in total

1.  State of the Art lecture. Risk mechanisms in hypertensive heart disease.

Authors:  E D Frohlich
Journal:  Hypertension       Date:  1999-10       Impact factor: 10.190

Review 2.  Left ventricular hypertrophy: pathogenesis, detection, and prognosis.

Authors:  B H Lorell; B A Carabello
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

Review 3.  Clinical practice. Diastolic heart failure.

Authors:  Gerard P Aurigemma; William H Gaasch
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

Review 4.  The heart in hypertension.

Authors:  E D Frohlich; C Apstein; A V Chobanian; R B Devereux; H P Dustan; V Dzau; F Fauad-Tarazi; M J Horan; M Marcus; B Massie
Journal:  N Engl J Med       Date:  1992-10-01       Impact factor: 91.245

Review 5.  Hypertensive heart disease. How does blood pressure affect left ventricular mass?

Authors:  L M Prisant; J L Houghton; P B Bottini; A A Carr
Journal:  Postgrad Med       Date:  1994-05-01       Impact factor: 3.840

6.  Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle.

Authors:  Michael R Zile; Catalin F Baicu; William H Gaasch
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

Review 7.  How can we diagnose coronary heart disease in hypertensive patients?

Authors:  L M Prisant; M J Frank; A A Carr; T W von Dohlen; A M Abdulla
Journal:  Hypertension       Date:  1987-11       Impact factor: 10.190

8.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

9.  Prognostic significance of left ventricular mass change during treatment of hypertension.

Authors:  Richard B Devereux; Kristian Wachtell; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine Harris; Peter Aurup; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

10.  Left ventricular hypertrophy as a risk factor: the Framingham experience.

Authors:  W B Kannel
Journal:  J Hypertens Suppl       Date:  1991-12
  10 in total
  11 in total

1.  Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.

Authors:  Jan Neckář; Libor Kopkan; Zuzana Husková; František Kolář; František Papoušek; Herbert J Kramer; Sung Hee Hwang; Bruce D Hammock; John D Imig; Jiří Malý; Ivan Netuka; Bohuslav Ošťádal; Luděk Červenka
Journal:  Clin Sci (Lond)       Date:  2012-06       Impact factor: 6.124

2.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).

Authors:  Elsayed Z Soliman; Walter T Ambrosius; William C Cushman; Zhu-Ming Zhang; Jeffrey T Bates; Javier A Neyra; Thaddeus Y Carson; Leonardo Tamariz; Lama Ghazi; Monique E Cho; Brian P Shapiro; Jiang He; Lawrence J Fine; Cora E Lewis
Journal:  Circulation       Date:  2017-05-16       Impact factor: 29.690

3.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.

Authors:  Elsayed Z Soliman; Robert P Byington; J Thomas Bigger; Gregory Evans; Peter M Okin; David C Goff; Haiying Chen
Journal:  Hypertension       Date:  2015-10-12       Impact factor: 10.190

4.  Electrocardiography for Assessment of Hypertensive Heart Disease: A New Role for an Old Tool.

Authors:  Giuseppe Mulè'; Emilio Nardi; Marco Guarneri; Santina Cottone
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-05-10       Impact factor: 3.738

5.  Ventricular hypertrophy blocked delayed anesthetic cardioprotection in rats by alteration of iNOS/COX-2 signaling.

Authors:  Leilei Ma; Feijuan Kong; Hongwei Ge; Jingquan Liu; Fangxiao Gong; Liang Xu; Bangchuan Hu; Renhua Sun
Journal:  Sci Rep       Date:  2014-11-17       Impact factor: 4.379

6.  Effects of Red Palm Oil on Myocardial Antioxidant Enzymes, Nitric Oxide Synthase and Heart Function in Spontaneously Hypertensive Rats.

Authors:  Emma Katengua-Thamahane; Barbara Szeiffova Bacova; Iveta Bernatova; Matus Sykora; Vladimir Knezl; Jacques Van Rooyen; Narcis Tribulova
Journal:  Int J Mol Sci       Date:  2017-11-21       Impact factor: 5.923

7.  Cardiovascular Disease, Diabetes Mellitus, and Hypertension in Lewy Body Disease: A Comparison with Other Dementia Disorders.

Authors:  Keivan Javanshiri; Mattias Haglund; Elisabet Englund
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 8.  Experimental Rodent Models of Cardiovascular Diseases.

Authors:  Tian Jia; Chen Wang; Zhengxi Han; Xiaozhi Wang; Ming Ding; Quanyi Wang
Journal:  Front Cardiovasc Med       Date:  2020-12-07

9.  May Measurement Month 2017-2019: A Community-Wide Opportunistic Blood Pressure Screening Campaign in Hong Kong.

Authors:  Joyce Tik Sze Li; Amy Shuk Man Lam; Brian Tomlinson; Vivian Wing Yan Lee
Journal:  Int J Hypertens       Date:  2021-01-16       Impact factor: 2.420

10.  Relationship of a new anthropometric index with left ventricular hypertrophy in hypertensive patients among the Han Chinese.

Authors:  Shuang Cai; Jing Dong; Bokai Cheng; Anhang Zhang; Jin Sun; Man Li; Yongkang Su; Qiligeer Bao; Ping Zhu; Shuxia Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-01-26       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.